Cite

HARVARD Citation

    Bhatnagar, B. et al. (2016). Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia. British journal of haematology. pp. 226-236. [Online]. 
  
Back to record